Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey

The Journal of Antimicrobial Chemotherapy
G BonfiglioG Nicoletti

Abstract

In order to assess the current level of resistance to widely used antipseudomonal antibiotics in clinical isolates of Pseudomonas aeruginosa, a national survey was undertaken. Fifteen hospitals throughout Italy participated in the study. The University of Catania tested the antibiotic susceptibility of 1005 consecutive clinically significant P. aeruginosa collected from March to June 1995. Lack of susceptibility, according to NCCLS breakpoints, was at the following rates: meropenem, 9.1%; imipenem, 19.3%; ceftazidime, 13.4%; carbenicillin, 27.3%; piperacillin, 12%; ticarcillin/clavulanic acid, 22.8%; amikacin, 10.6%; and ciprofloxacin, 31.9%. About half of the isolates (44.4%) were not susceptible to at least one of the antibiotics tested.

Citations

Jan 9, 1999·Burns : Journal of the International Society for Burn Injuries·A Rastegar LariR Alaghehbandan
Oct 29, 2000·International Journal of Antimicrobial Agents·H Giamarellou
Jun 7, 2003·International Journal of Antimicrobial Agents·J A A Hoogkamp-KorstanjeUNKNOWN Susceptibility Surveillance Study Group
Mar 18, 2000·International Journal of Antimicrobial Agents·A SpecialeM Renis
Jun 25, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·M L MoroC Gandin
Jun 10, 2009·Journal of Biochemistry·Tatsushi MogiKiyoshi Kita
Jan 25, 2003·Antimicrobial Agents and Chemotherapy·Giovanni Pietro GesuAnnalisa Cavallero
Dec 14, 2011·International Journal of Microbiology·Tamil Selvi Sivanmaliappan, Murugan Sevanan
May 12, 2005·Chemotherapy·Giovanni BonfiglioUNKNOWN Italian Medici Medicina Generale (MMG) Group
Apr 2, 2002·Expert Opinion on Investigational Drugs·Giovanni BonfiglioGiuseppe Nicoletti
Jun 15, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G M Rossolini, E Mantengoli
Nov 30, 2005·Archives of Medical Research·Shankar Esaki MuthuUsha Anand Rao
Nov 8, 2002·Journal of Chemotherapy·R FontanaL Franchino
Apr 20, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Mari MizutaEbbing Lautenbach
Oct 2, 2008·Biological & Pharmaceutical Bulletin·Kumiko MaedaAkira Kamiya
Mar 13, 2015·Iranian Red Crescent Medical Journal·Nastaran Fazeli, Hassan Momtaz
Jan 30, 1999·Antimicrobial Agents and Chemotherapy·B SegatoreG Amicosante
Oct 9, 1999·Journal of Natural Products·P GuiraudN Buarque De Gusmao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.